Elsevier | Life Sciences

Your research doesn't end when you find the right clinical trial - it starts there. Soon, you'll be able to take richer clinical trial data further into your workflow - supporting evidence synthesis, reporting, regulatory work and downstream analysis. Built on a growing evidence base of 51.5+ million records, including 37,000 new ClinicalTrials.gov records added in 2026 and supported by expanded export capabilities, Embase is helping researchers work more efficiently from discovery to decision-making. #Embase #EvidenceBasedResearch #MedicalResearch #ClinicalResearch

Don’t bite off more than you can chew by trying to develop a general data strategy. Instead, according to Dr. Marc Feldmann, senior principal at AI consulting firm Alexander Thamm [at], you should start by asking yourself: What business problem am I trying to solve? Hear more advice from Dr. Feldmann and other R&D leaders by watching our recent webinar “Driving innovation with agentic AI”: http://spkl.io/60457zs69 #AIinRD #AI #AgenticAI #Innovation

Build your next discovery on trusted evidence. Use the quieter weeks of August to explore the Life Sciences track of the Insight to Impact webinar series, now available to watch on demand. Discover how Embase and Reaxys can help you strengthen evidence, accelerate discovery and make more informed research decisions with trusted data and AI-enhanced workflows. 🎥 Watch on demand • Accelerating Biomedical Insights: Best Practices for Using Embase AI in Literature Search • Improving Your Document Searches and Retrosynthesis Plans with Reaxys AI-Enhanced Capabilities 📅 Register for upcoming live session • Leveraging Embase for regulatory excellence: Optimizing literature searches in pharmacovigilance and medical device compliance and development Whether you're conducting literature reviews, planning synthesis routes or exploring AI-enhanced research workflows, these expert-led sessions offer practical guidance to help you work more efficiently and with greater confidence. ➡️ Explore the Life Sciences track: http://spkl.io/60487MUNC #InsightstoImpact #Embase #ReaxysAI

Similar reactions, grouped by conditions. Compare reagents, catalysts, solvents, similarity, median yields and supporting examples without opening reaction records one by one. Explore in Reaxys: http://spkl.io/60437zS5S #Reaxys #DiscoveryChemistry #SynthesisPlanning #MedicinalChemistry

A literature summary is useful. A cited research report with scope, assumptions, limitations and traceable sources is more useful before R&D work moves forward. LeapSpace Deep Research helps life sciences teams ask complex questions, review a structured report and inspect the cited evidence behind the output. Use it to support: • Target or mechanism exploration • Clinical evidence review • Product claim or safety rationale work Explore Deep Research: http://spkl.io/60437KbUt #LeapSpace #DeepResearch #Research #EvidenceBased

When a reaction record looks relevant, do not stop at the record. Conditions Navigator helps medicinal and process chemists move from one reaction to similar condition evidence, making it easier to compare what has worked across Reaxys reaction data before the next synthesis decision. Explore in Reaxys: http://spkl.io/60437Kl4Z #Reaxys #DiscoveryChemistry #SynthesisPlanning #MedicinalChemistry

“I think you cannot have sophisticated agentic frameworks without semantics because, at the end of the day, there is a massive amount of governance and processes that the agent needs to be aware of if you’re going to use this agent in real life.” -- Helena Deus, Bristol Myers Squibb Learn more about what Helena and other R&D leaders think about agentic AI by watching the full webinar: http://spkl.io/60427zSC2 #AIinRD #AI #AgenticAI #Innovation

What if your next search could reveal more than you expected? Finding evidence is only the beginning. Soon, Embase will make it easier to explore richer clinical trial information—from study design and investigators to linked publications and structured metadata. With daily synchronization from ClinicalTrials.gov, comprehensive trial records, and powerful Emtree indexing, you'll have even more confidence that you're seeing the complete evidence picture. #ClinicalResearch #MedicalInformation #Embase #Clinicaltrials

From COVID-19 to the next unknown outbreak, vaccine R&D speed matters. In this month's edition of our newsletter, discover how the Vaccine Ontology (VO) is turning messy biomedical data into a standardized, machine-readable map covering 10,000+ vaccines across 30+ species — fueling AI-driven discovery and safer, faster science. Read now! #VaccineOntology #AIinHealthcare #Ontology #Immunology #Elsevier #SciBite

“The pace of change now is just insane,” marveled Brent Railey of Chevron Phillips Chemical Company in a recent webinar on agentic AI. Organizations must manage a complicated balancing act as they try to seize the right opportunities while still being realistic about the fact that the “latest and greatest” technology could be obsolete in a year. Watch the full webinar to learn how Brent and other R&D leaders are navigating the rapidly-changing AI tech landscape: Watch “Driving innovation in agentic AI” to learn more: http://spkl.io/60427zS7Y #AIinRD #AI #AgenticAI #Innovation